medullary thyroid cancer and semaglutide Can Cause Cancer? Know the Potential GLP-1 Risks Understanding the Link Between Ozempic

Please, protect...

Make an informed decision about whether and how to incorporate GLP-1s into your employee benefits strategy, with insights from our chief medical officer.

Leading up to #ASCO25, Monica Avila, MD, highlights promising research showing GLP-1 drugs may lower the risk of obesity-related cancers, especially in women with diabetes

New trial data for Amgen's GLP-1 drug MariTide shows a weight loss of 20 percent in non-diabetic participants with obesity or overweight.

Refreshing Lemon Lime Seltzer with 40 g of Protein

Peroxisome proliferator-activated receptor (PPAR) plays an essential role in mitochondrial function and glucose homeostasis